Strategic partnership: CorTec and Heraeus Medevio join forces in neuromodulation

Freiburg-based CorTec GmbH and Heraeus Medevio, headquartered in Minneapolis, USA, have entered into a strategic partnership in the field of neuromodulation. The aim of this collaboration is to offer customers a seamless solution—from early-stage development to full-scale manufacturing—of implantable medical devices.

CorTec contributes its expertise in developing, prototyping, and small-series production of advanced neuro-electrodes, while Heraeus Medevio serves as a trusted industrial partner for scaling up to high-volume manufacturing. Together, they will provide comprehensive support to OEMs and help bridge a critical gap in the rapidly growing neuromodulation market.

Transatlantic Collaboration for Next-Generation Implantable Medical Technologies

By combining their strengths, both companies aim to set new standards in quality, innovation, and customer service. Initial mass production of electrodes based on CorTec’s patented laser microfabrication technology is expected to begin by the end of 2025. The partnership marks a significant step forward in accelerating global medical innovation through integrated, transatlantic cooperation.